scholarly journals To Evaluated The Changes In Quality Of Life With Chronic Daily Headache

2018 ◽  
Vol 4 (2) ◽  
Author(s):  
S. P. Agiwal
Keyword(s):  
Quality Of Life ◽  
Chronic Daily Headache ◽  
Daily Headache

scholarly journals Chronic daily headache: stress and impact on the quality of life

2007 ◽  
Vol 65 (4b) ◽  
pp. 1126-1129 ◽  
Author(s):  
José Carlos Busto Galego ◽  
Avelina Maria Moraes ◽  
José Antonio Cordeiro ◽  
Waldir Antonio Tognola
Keyword(s):  
Quality Of Life ◽  
Chronic Daily Headache ◽  
Short Form ◽  
Bodily Pain ◽  
Primary Headache ◽  
Medical Outcomes ◽  
Stress Symptoms ◽  
Sf 36 ◽  
Daily Headache

OBJECTIVE: To evaluate the stress presence and its influence in the quality of life of patients with chronic daily headache (CDH). METHOD: A hundred patients with at least 18 years old, with primary headache with duration greater than 4 hours a day, and frequency of 15 or more days monthly for at least three months were studied. Lipp's Inventory of Stress Symptoms and the Medical Outcomes Study Short Form (SF-36) were used. RESULTS: Stress was observed in 90% of the patients; nearly half of them was in the phase almost exhaustion. Patients with stress when compared with the ones with no stress presented significantly lower scores in all the domains of SF-36; except in physical functioning. The resistance phase presented scores significantly higher than almost exhaustion; except for bodily pain. CONCLUSION: The majority of the patients presented stress with significant reduction in their quality of life. Consequently, the stress could be related with both the development and the maintenance of CDH.

Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life

Neurology ◽  
2004 ◽  
Vol 62 (8) ◽  
pp. 1338-1342 ◽  
Author(s):  
R. Colas ◽  
P. Munoz ◽  
R. Temprano ◽  
C. Gomez ◽  
J. Pascual
Keyword(s):  
Quality Of Life ◽  
Chronic Daily Headache ◽  
Daily Headache

Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review

Cephalalgia ◽  
2011 ◽  
Vol 31 (7) ◽  
pp. 837-850 ◽  
Author(s):  
Michel Lantéri-Minet ◽  
Gérard Duru ◽  
Mia Mudge ◽  
Suzi Cottrell
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Chronic Migraine ◽  
Economic Burden ◽  
Chronic Daily Headache ◽  
Medication Overuse ◽  
Negative Impact ◽  
Productivity Loss ◽  
Daily Headache

Objective: To evaluate the evidence for quality of life (QoL) impairment, disability, healthcare resource use and economic burden associated with chronic daily headache (CDH), focusing on chronic migraine (CM) with or without medication overuse. Methods: A systematic review and qualitative synthesis of studies of patients/subjects with CDH that included CM, occurring on at least 15 days per month. Main findings: Thirty-four studies were included for review (25 studies of patients and nine of subjects from the general population). CDH and CDH with medication overuse headache (MOH) were consistently associated with a lower QoL compared to control or episodic headache (EH) and CDH without MOH. CDH was consistently associated with greater disability and productivity loss, more consultations, more or longer hospitalizations and higher direct costs than EH. Data were not amenable to statistical pooling. Principal conclusions: The findings of this review underline the detriment to QoL and the disabling nature of CDH, and in particular CM and CDH with MOH, and negative impact on workplace productivity compared to other types of headache.

scholarly journals Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headache

2008 ◽  
Vol 9 (6) ◽  
pp. 349-357 ◽  
Author(s):  
Sergio De Filippis ◽  
Denise Erbuto ◽  
Federica Gentili ◽  
Marco Innamorati ◽  
David Lester ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Daily Headache ◽  
Suicide Risk ◽  
Illness Perception ◽  
Daily Headache

scholarly journals Psychopathology and quality of life burden in chronic daily headache: influence of migraine symptoms

2010 ◽  
Vol 11 (3) ◽  
pp. 247-253 ◽  
Author(s):  
A. Autret ◽  
◽  
S. Roux ◽  
S. Rimbaux-Lepage ◽  
D. Valade ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Daily Headache ◽  
Daily Headache

Levetiracetam in chronic daily headache: A double-blind, randomised placebo-controlled study

Cephalalgia ◽  
2010 ◽  
Vol 31 (5) ◽  
pp. 530-536 ◽  
Author(s):  
Roy G Beran ◽  
Paul J Spira
Keyword(s):  
Quality Of Life ◽  
Mental Health ◽  
Diagnostic Criteria ◽  
Chronic Daily Headache ◽  
Life Assessment ◽  
Phase Iii ◽  
Controlled Study ◽  
Primary Efficacy ◽  
Daily Headache

Introduction: Chronic daily headache (CDH) represents a temporal profile of headache (15+ days/month; 4+ hours/day; >6 months). We report the first comprehensive and largest levetiracetam (LEV) trial in CDH. Methods: A 27-week, multi-centre, randomised, placebo-controlled, cross-over, phase III B study assessed efficacy of a target of 3 g/day LEV of 6 placebo tablets/day in CDH. Primary efficacy was headache-free rate (HFR) while secondary parameters were loss of diagnostic criteria; severity; duration; disability; associated features; pain; and quality of life. Results: Ninety-six patients were recruited (baseline HFR 10.4 ± 14.6%; median 0%). At onset of history 73 (74.1%) had migraine +/− aura and 35 (36.5%) had tension-type headache (TTH). Over the six months preceding recruitment 54 (56.3%) had migraine and 42 (43.8%) had TTH. Headache history was 22.6 ± 15.0 years (median 20.0). Eighty-eight received placebo and 89 received LEV with >80 receiving stable dose in either arm. LEV achieved 3.9% increased HFR over placebo, showing a trend but not significance. There was 9.9% increase in loss of CDH diagnostic criteria re: headache days/month for LEV over placebo ( p = .0325), reduced disability ( p = .0487) and reduced pain severity for LEV ( p = .0162). The Short-Form Quality of Life assessment instrument (SF-36) showed impaired mental health on LEV ( p = .001). Discussion: These findings conflict with reports of LEV efficacy, mandating placebo control in headache trials. Primary efficacy equated to one extra headache-free day/month with reduced disability and pain intensity. Mental health was reduced on LEV. The 10% loss of diagnostic criteria, decreased intensity and disability suggest a subpopulation with CDH where LEV remains a therapeutic option.

Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life

Neurology ◽  
2004 ◽  
Vol 63 (7) ◽  
pp. 1341-1341 ◽  
Author(s):  
V. K. Gupta ◽  
J. Pascual ◽  
R. Colas ◽  
P. Munoz
Keyword(s):  
Quality Of Life ◽  
Chronic Daily Headache ◽  
Daily Headache
Sign in / Sign up

Export Citation Format

Share Document